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Abstract
Thoracic cancer treatment presents dosimetric difficulties due to respiratory motion and lung inhomogeneity. Monte 
Carlo and deformable image registration techniques have been proposed to be used in four-dimensional (4D) dose 
calculations to overcome the difficulties. This study validates the 4D Monte Carlo dosimetry with measurement, 
compares 4D dosimetry of different tumor sizes and tumor motion ranges, and demonstrates differences of dose-
volume histograms (DVH) with the number of respiratory phases that are included in 4D dosimetry. BEAMnrc was used 
in dose calculations while an optical flow algorithm was used in deformable image registration and dose mapping. 
Calculated and measured doses of a moving phantom agreed within 3% at the center of the moving gross tumor 
volumes (GTV). 4D CT image sets of lung cancer cases were used in the analysis of 4D dosimetry. For a small tumor 
(12.5 cm3) with motion range of 1.5 cm, reduced tumor volume coverage was observed in the 4D dose with a beam 
margin of 1 cm. For large tumors and tumors with small motion range (around 1 cm), the 4D dosimetry did not differ 
appreciably from the static plans. The dose-volume histogram (DVH) analysis shows that the inclusion of only extreme 
respiratory phases in 4D dosimetry is a reasonable approximation of all-phase inclusion for lung cancer cases similar to 
the ones studied, which reduces the calculation in 4D dosimetry.
Introduction
Monte Carlo simulation is the most accurate radiation
dose calculation algorithm in radiotherapy [1,2]. With the
advent of increasingly fast computers and optimized
computational algorithms, Monte Carlo methods prom-
ise to become the primary dose calculation methodology
in future treatment planning systems [3-6]. Thoracic
tumor motion could introduce discrepancies between the
dose as planned and actually delivered, both to the tumor
and the surrounding normal lung [7]. Incorporating
Monte Carlo methods into 4-dimensional (4D, 3 spatial
dimensions plus time) dosimetry and treatment planning
yields the most accurate dose calculations for thoracic
tumor treatments [8,9].
T o generate a 4D Monte Carlo dose calculation, it is
necessary to calculate the dose on CT image sets derived
from different time points across the respiratory cycle.
These can then be fused together to calculate cumulative
doses. Deformable image registration is an integral part
of this process. It provides a voxel-to-voxel link between
the multiple respiratory phases of a 4D CT image set so
that the dose distribution on each phase can correctly be
summed to give a path-integrated average dose distribu-
tion [10,11]. Deformable image registration across the
various phases of a 4D CT image set has become a new
focus of study [10,11].
In this study, 4D Monte Carlo dosimetry was presented.
The 4D cumulative point dose in a moving phantom was
compared with measurement. Clinical lung cancer cases
were studied with the goal of determining under which
conditions 4D Monte Carlo dosimetry likely differs from
a static plan and how many respiratory phases are neces-
sary to be included in 4D dose calculation.
Materials and methods
CT-Based Treatment Planning
A total of four CT simulation image sets were used in this
study. Two were performed on actual patients. Two lung
cancer patients underwent 4D CT scanning (Case 1 and
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Case 2). These 4D CT data sets were comprised of a total
of 10 CT scans per patient, taken at equally-spaced inter-
vals across the entire respiratory cycle (phase-based sort-
ing in 4D CT reconstruction). There were 93 and 94 slices
in each respiratory phase of the two 4D CT cases, respec-
tively. The GTV moved about 1.5 cm during the respira-
tory cycle in Case 1 and 1.0 cm in Case 2, predominantly
in the SI direction. The GTV volume for Case 1 was 12.5
cm3 (about 3 cm in diameter) while for Case 2 it was
159.1 cm3 (about 7 cm in diameter). For the last two
cases, 4D CT image sets were generated from a moving
phantom with two different motion ranges, to compare
the 4D cumulative doses with actual measurements. The
4D scans of the moving phantom contained 90 slices in
each of the ten respiratory phases. All 4D CT imaging
was performed on a 16-slice Big Bore CT scanner (Philips
Medical Systems, Andover, MA). The transaxial slice res-
olution was about 1 mm × 1 mm and the slice thickness
was 3 mm for all scans.
The moving phantom was custom-designed (Figure 1).
Phantom motion was controlled by a motor with adjust-
able rotational frequency. A rotating wheel connected to
the motor. The wheel contained holes at various dis-
tances from the axis of rotation, which thereby deter-
mined the magnitude of the range of the sinusoid motion
of the phantom, which is the only motion pattern the
table can perform. The phantom container was made of
acrylic. Cork blocks with density of 0.26 g/cm3  were
placed inside the acrylic container to simulate normal
lung. An acrylic rod of 3 × 3 × 2 cm3 was placed in the
center of the cork blocks to simulate a tumor. The center
of this rod contained a 0.04 cc Scanditronix CC04 ion
chamber (active length 3.6 mm, inner radius 2 mm) to
measure the point dose. The motion range was set to 1.5
(Case 3) or 3 cm (Case 4) at a frequency of about 18
cycles per minute to simulate respiration. The same
motion pattern was used during both the 4D CT scan and
treatment delivery.
A treatment plan was generated for each of the four CT
data sets. Simple 3D-conformal plans were utilized. All
the plans were calculated for a Varian Clinac 2100EX lin-
ear accelerator (Varian Medical Systems, Palo Alto, CA).
Photon beams of 6 MV in energy were used. The margin
from gross tumor volume (GTV) to block edge is 0.5 cm
(Case 2) and 1 cm (Case 1, 3 and 4). MLC was used for
the conformal plans in Case 1 and 2. Open 5 × 5 cm2
beams were used in the phantom study cases due to the
regular shape of the acrylic rod which simulated the GTV.
For Case 1 and Case 2, the tumors were contoured on
the maximum inspiration phase of the respective 4D CT
image sets and the isocenters were set accordingly. A 3D
plan was then generated for each patient. For Case 1, a
wedged 3-beam 3D plan was created. A wedged two-field
3D-conformal plan was designed for Case 2. The respec-
tive treatment plans were then copied over from the max-
imum inspiration scan to each of the other nine phases of
the CT scan for that patient. A Monte Carlo simulation
was used to calculate the dose distribution on each phase.
The dose distributions from all other phases were
mapped to the maximum inspiration phase using defor-
mation matrices generated via deformable image registra-
tion between all the other phase and the maximum
inspiration phase. A 4D cumulative dose distribution was
created from an equally-weighted average of the dose dis-
tributions. This 4D Monte Carlo dosimetry method was
applied to the two cases over all ten phases (vide infra). A
dose-volume-histogram (DVH) was obtained for each of
the respiration phases and the 4D integrated DVH was
obtained from the 4D cumulative dose distribution.
For the moving phantom cases, a lateral-opposed 2-
beam plan was designed to cover the simulated tumor
during the maximum inspiration phase. These beams
were copied to the nine other phases of CT scans and the
doses were calculated using Monte Carlo methods (vide
infra). The 4D cumulative doses were generated.
Table 1 lists the tumor sizes, motion ranges and beam
margins for all the cases studied. The beam margins are
purposely set smaller than the motion ranges to gauge the
coverage loss effects.
Monte Carlo Dose Calculation
BEAMnrc [1] was used to simulate the linear accelerator.
This is a Monte Carlo simulation application based on
EGSnrc [12], a software package designed for Monte
Carlo simulation of coupled electron-photon transport.
The simulated incident electron beam bombarding the
tungsten target was a 6 MeV pencil beam with a 2-dimen-
sional Gaussian distribution of full width at half maxi-
mum (FWHM) of 0.1 cm [1,12]. For each treatment
beam, the linear accelerator was simulated to generate a
phase-space file containing information about each parti-
cle exiting the treatment head of the machine, as it
Figure 1 A. The moving phantom was controlled by a motor with 
variable rotation frequency. The rotation wheel had variably-spaced 
holes in the radial direction which controlled the motion range. B. The 
phantom had cork placed within an acrylic container to simulate lungs. 
An acrylic rod was placed within the cork to simulate a tumor. An ion 
chamber was inserted into the acrylic rod to measure the point dose.Huang et al. Radiation Oncology 2010, 5:45
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existed at 60 cm from the electron source. The percent-
age depth dose curves and profiles in a water phantom
from Monte Carlo simulations were matched with the
measured data within 2% for most of the low gradient
dose regions and slightly over 2% at the shoulders of one
of the profiles. In regions of build-up or penumbra, the
distance between calculated and measured curves was
within1 mm.
Another EGSnrc based software, DOSXYZnrc [13],
was used for dose calculations in the patient/phantom
through the various respiratory phases. Additionally, CT-
to-phantom converter code, ctcreate [14], was used to
convert the patient/phantom CT image data to CT phan-
tom data that DOSXYZnrc could use. For the patient
cases (Case 1 & 2), AIR, LUNG, ICRUTISSUE and ICRP-
BONE were used for air, lung tissue, soft tissue and bone
media respectively based on their CT number ranges,
while for the phantom cases (Case 3 & 4), AIR, LUNG
and PMMA were used for air, cork and acrylic respec-
tively. Dosimetrically, cork is equivalent to lung tissues
[15,16]. The dose grid size used for this study was 2 × 2 ×
3 mm3, which is coarser than the CT image resolution of
1 × 1 × 3 mm3. Each CT slice was therefore sub-sampled
from 512 × 512 pixels to 256 × 256 pixels to match the
Monte Carlo dose grid size before the CT-to-phantom
conversion. The phase-space files were then used as the
particle source to calculate the dose distribution for each
respiratory phase in the patients and phantom. In order
to achieve acceptable statistical uncertainties in target
volume (about 1%), the particles stored in the phase space
files were recycled 4 times. No specific variance reduc-
tion technique was applied. The cutoff energies for elec-
trons (ECUT) and for photons (PCUT) were 0.7 and 0.01
MeV respectively. Dose calculation for one respiratory
phase took about 20 hours of CPU time on a 2.66 GHz
single-processor personal computer with 2 GB RAM,
running Linux.
Deformable Image Registration
The optical flow method of deformable image registra-
tion was then applied to calculate the deformation matri-
ces between the CT images from the different respiratory
phases. These matrices were used to map the dose distri-
butions from the various respiratory phases to an average
integral dose. The 3D optical flow program was based
upon the 2D Horn and Schunck algorithm [11,17].
For typical 4D CT image sets with a sub-sampled slice
resolution of 2 × 2 mm2/pixel, each deformable image
registration required about three minutes on a personal
computer with a single 2.66 GHz CPU and 4 GB RAM.
Thus, for a respiratory cycle divided into 10 phases, about
half an hour was required to calculate all the deformation
matrixes.
Results
Moving Phantom Study
Absolute dose was used in the 4D dosimetry of the mov-
ing phantom by normalizing the dose matrix to the refer-
ence dose which was the maximum value of the central
depth dose of a 10 × 10 cm2 field at 100 cm of source to
surface distance (SSD). This absolute dose conversion
assumed that the Monte Carlo calculated reference dose
was 1 cGy per monitor unit (MU) which agreed with the
accelerator calibration.
With different motion ranges, the central point dose
measurements and 4D dose calculations showed an
agreement better than 3%. With a tumor motion range of
3 cm (Case 4), the measured central point dose for a 5 × 5
cm2 field demonstrated a 27.5% ± 0.7% drop compared to
the static phantom case, while the 4D dosimetry calcula-
tion showed a 25.0% ± 1.1% drop. With a motion range of
1.5 cm (Case 3), the central point dose was equivalent for
both the phantom measurement and 4D dose calculation
due to the fact that the central point was well covered by
the treatment beams, given the relatively short motion
range.
Lung Tumor Treatment Plans
Figure 2 compares the Monte Carlo static dose distribu-
tion on the maximum inspiration phase (Figure 2A-B)
with the static dose of the maximum expiration phase
mapped onto the maximum inspiration phase image (Fig-
Table 1: Relevant parameters in the cases studied
C a s e 1234
Subject Patient Patient Phantom Phantom
GTV size/cc 12.5 159.1 18.0 18.0
M o t i o n  r a n g e / c m 1 . 51 . 01 . 53 . 0
Margin/cm 1.0 0.5 1.0 1.0Huang et al. Radiation Oncology 2010, 5:45
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ure 2C-D). The distribution of the mapped dose is shifted
inferiorly towards the diaphragm, and the tumor is closer
to the superior aspect of the isodose distribution (Figure
2D) .  T he  r eason f or t his is  t ha t  in t he  dia phra gm  and
tumor move upward in the maximum expiration phase
while the beams remain fixed. Consequently, the dose
distribution on the maximum expiration phase moves
inferiorly relative to the diaphragm or tumor. Therefore,
after the dose distribution is mapped onto the maximum
inspiration phase, the isodose distribution skews inferi-
orly.
Figure 3 shows a DVH of the GTV coverage at various
phases of the respiratory cycle together with the 4D
cumulative dose DVH. At the prescribed dose of 70 Gy,
the static plan shows 95% GTV coverage in the maximum
inspiration (0%) phase while the average dose plan only
shows tumor coverage of 80%. The worst phase (50% or
70% in the figure) shows slightly better than 70% coverage
of the GTV. In this example, the GTV moved about 1.5
c m  i n  t h e  S I  d i r ect i o n .  W i t h  a  be a m  m a r gi n  o f  1  c m ,
tumor coverage was clearly reduced.
In general, the DVH of the 4D cumulative dose distri-
bution from the mapped doses lies between the opti-
mized static dose DVH at the maximum inspiration (0%)
phase and the maximum expiration (50%) phase. How-
ever, at times, it can exceed or trail the curve for any indi-
vidual phase. In Figure 3, at the low-dose portion of the
curve, around 66 Gy, the volume covered by the average
dose is higher than that for any of the static respiratory
phases. Correspondingly, at the high dose tail (above 75
Gy), the average dose curve is lower than that for any
individual respiratory phase. This behavior of the DVH
curves in Figure 3 indicates that the 4D cumulative dose
reduced the magnitude of hot/cold spots in individual
static plans.
When evaluating a treatment plan, one also needs to
consider the DVH curves for the normal structures. In
particular, different portions of lung move in and out of
the treatment field, which causes the 4D cumulative lung
DVH to vary from that for any given respiratory phase.
This is evident in Figure 4.
We next investigated how many respiratory phases are
necessary to include in the 4D calculations to reasonably
estimate the average dose to the GTV as calculated when
incorporating all ten respiratory phases. Figure 5 shows a
comparison of several GTV DVH curves from Case 1,
including curves from the extreme static phases and the
lowest GTV coverage phase (30%) as references. The cal-
Figure 2 Case 1 comparison of the Monte Carlo calculated static 
dose during the maximum inspiration phase (panels A and B), 
and the mapped static dose of the maximum expiration phase 
viewed on the maximum inspiration phase (panel C and D). The 
original static plan was optimized on the maximum inspiration phase. 
The coronal view of the mapped dose (panel D) shows that the tumor 
is closer to the upper isodose lines, which is expected because the tu-
mor moves superiorly in the maximum expiration phase. The green 
lines on panel B and D indicate the GTV superior edge.
Figure 3 Dose-volume histograms (DVH) of the gross tumor vol-
ume (GTV) from various static respiratory phases (0%, 20%, 50%, 
70%, and 90%) as well as the 4D cumulative dose DVH (average) 
for Case 1. In the static plan from the 0% phase, the GTV coverage at 
the prescribed dose of 70 Gy is about 95%, while it is 80% for the 4D 
cumulative dose.
Figure 4 Left lung DVHs from various static image sets (0%, 50%, 
90%) and the 4D cumulative DVH (Case 1). For the 50% phase, the 
diaphragm started moving superiorly into the field, causing less lung 
being irradiated at this phase, thereby reducing the lung DVH.Huang et al. Radiation Oncology 2010, 5:45
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culated average doses included the doses as mapped from
a variable number of the respiratory phases, using
deformable image registration, ranging from two (0% and
50%), to five (0%, 20%, 50%, 70% and 90%), to all the 10
phases. By observation, the inclusion of increasing num-
bers of respiratory phases in the 4D dose calculation
improves agreement with the calculation derived from
using all ten phases. However, considering that both
Monte Carlo simulation and deformable image registra-
tion are time consuming calculations, the DVH of the
cumulative dose using just the two extreme phases is a
reasonable representation of the average derived when
incorporating all ten phases.
In Case 2, the GTV motion is about 1 cm, but the DVH
variation is much smaller than that in Case 1 even with a
block margin of 0.5 cm across the GTV (Figure 6). This
can be explained by the fact that the GTV is much larger
in Case 2 (159.1 cm3) than in Case 1 (12.5 cm3). This
translates into a much smaller percentage volume change
for Case 2 when compared to Case 1.
Discussion
In this study, discrepancy between a point dose measure-
ment in a moving phantom and the calculated 4D cumu-
lative dose was less than 3%. The variance is
multifactorial, representing a combination of errors from
Monte Carlo simulation, image registration, and phan-
tom measurements.
In the Monte Carlo simulations, the statistical uncer-
tainties in the high dose regions, such as the GTV, are
below 1%. Other error sources include electron source
parameters, linear accelerator geometry and materials.
Any discrepancies of these items between simulation and
reality could introduce variability between calculations
and measurements. As shown previously, these differ-
ences were within 2% for most cases in our study.
Errors in image registration can also affect the calcu-
lated dose. There are three root causes for errors in image
registration. Artifacts in the 4D CTs, the aperture effect
[18], and the inherited occlusion problem [19] all intro-
duce potential sources for error in image registration. In
our experience, 4D CT artifacts are the major contribut-
ing factor to errors in image registration. The 4D CT arti-
facts are caused by residual motion in each respiration
phase which smears details in 4D CT images. Since accu-
rate optical flow registration depends upon clarity of the
details in each image, any degradation in image quality
can impact the quality of registration.
The aperture effect is introduced in regions of flat
intensity within the images. When there is no variation in
intensity within a region, the voxel-to-voxel correspon-
dence becomes vague. Thus the registration may have
larger errors in low contrast regions. For human CT data,
detailed anatomic structures, such as veins, help reduce
the aperture effect. Our prior research has shown that the
average magnitude of this error is smaller than an image
voxel size in the thoracic regions [20]. Another study by
Zhong et al [21] showed that the average error in lungs by
Demons, another deformable image registration algo-
rithm that is similar to optical flow, was around 0.7 mm,
but larger in the low gradient prostate region.
Figure 5 Comparison of the 4D cumulative dose (average) DVH 
for the GTV when incorporating different numbers of respiratory 
phases into the calculations (Case 1). By incorporating additional 
phases, the accuracy of the dose calculation improved. However, the 
use of just two phases (0% and 50%, the maximum inspiration and 
maximum expiration respectively based on diaphragm motion) pro-
vides a reasonable approximation. The dose difference for the same 
volume coverage between each of the three averaged DVH curves is 
less than 0.5 Gy. The lowest GTV coverage occurred at 30%, which is 
shown in this figure too for reference.
Figure 6 GTV DVH curves from various static respiratory phases 
(0%, 20%, 50%, and 90%) and the 4D cumulative dose for Case 2. 
The GTV was large (159.1 cm3) in relation to the tumor motion (1 cm). 
This is in contrast to Case 1, which had a similar range of tumor motion, 
but for a tumor which measured only 12.5 cm3. Consequently, the DVH 
curve for the average dose does not differ much from the static DVH 
curves (Figure 3).Huang et al. Radiation Oncology 2010, 5:45
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Occlusion may cause motion discontinuity in other
image registration applications, such as daily patient CT
registration when rectal filling varies. For 4D CT images,
occlusion is not a problem since there is no topological
change between the respiratory phase images.
The Monte Carlo method applied in this study is a clas-
sical full Monte Carlo method. The calculation time was
long for each case. In recent a few years, various tech-
niques have helped in increasing the computational effi-
ciency of Monte Carlo simulation and reducing its
calculation time [3,22-24]. Using multiple source models
instead of simulating phase-space files would also reduce
calculation time significantly [24]. By applying these
modifications, some simpler and faster Monte Carlo
methods have already been implemented in commercial
treatment planning systems or demonstrated to be rea-
sonable for clinical application [25-27]. With faster com-
puters and high efficient Monte Carlo algorithms, multi-
phase Monte Carlo dose calculations have been demon-
strated feasible for clinical applications [27]. If fewer
phases are used for 4D dose calculations, the work load is
also correspondingly reduced. Another way to further
reduce the computation time is to lower the simulation
histories in each respiration phase. With a higher statisti-
cal uncertainty in each respiration phase, the statistical
uncertainty of the 4D cumulative dose remains at an
acceptable level [8]. The 4D Monte Carlo dose calculation
can be reduced to a single calculation on the average CT
if the simplified 4D dose accumulation method proposed
by Glide-Hurst et al [28] is applied.
In our 4D test cases, the method noticeably altered the
dose calculation compared to static plans only when the
tumor was small and the respiratory motion was compar-
atively large.
Vinogradskiy et al [29] demonstrated by measurement
that 4D dose calculations provided greater accuracy than
3D dose calculations in heterogeneous dose regions. Rosu
et al [30] studied how many phases are needed in 4D
cumulative dose calculation for various clinical end
points and concluded that results using only two extreme
phases in 4D cumulative dose calculation agreed well
with those of full inclusion for the 4 cases studied. This
study confirmed their conclusion with Monte Carlo cal-
culations.
The treatment plans generated for this study were not
intended for clinical use. The phase for the original plan
was randomly picked between the two extreme phases
and the isocenter was placed on the GTV center of the
corresponding phase. The margins in the plans were pur-
posely set small compared to the motion ranges so that
target volume coverage loss, thus DVH variation of the
target volume versus respiratory phase, was more pro-
nounced. The conditions used in our study tended to
exaggerate coverage loss and hence was more adverse
against the above conclusion. The conclusion is thus
deemed more confident when applied to real clinical
cases which are usually with better coverage. However,
due to limited number of cases studied, this conclusion
should not be applied to cases of larger or irregular
motions. When large motion is reduced to be within cer-
tain range (< 1 cm) by applying a motion-reducing tech-
nique, such as abdominal compression which is often
u s e d  i n  s t e r e o t a c t i c  l u n g  t r e a t m e n t s ,  t h i s  c o n c l u s i o n
should apply as long as the beam margins are large
enough for the motion ranges.
Monte Carlo methodology provides more accurate
dose calculation across an inhomogeneous substrate such
as the lung [31]. For some extrathoracic sites, such as the
abdomen, respiratory motion of tumors and normal
structures is not insignificant [32]. Therefore, 4D dose
calculations might also prove useful in the treatment of
abdominal tumors. When lung or any other significant
inhomogeneous substrate is not involved in treatment
volumes, Monte Carlo methods may be replaced by other
faster dose calculation algorithms in 4D dose calculations
with an acceptable accuracy.
Conclusions
With the combination of Monte Carlo simulation and the
optical flow method, 4D dosimetry is proved accurate
based on point-dose measurement in a moving phantom.
Monte Carlo 4D dose calculation would provide a
planned dose distribution that is closer to the delivered
dose than a static plan does, especially when dose varia-
tion is large between respiratory phases. Based on the
cases studied, large dose variation between respiratory
phases is more likely for small tumor volumes with rela-
tively large motion. The inclusion of only two extreme
respiratory phases in 4D cumulative dose calculation
would be a reasonable approximation to all-phase inclu-
sion for cases similar to the ones studied.
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